|Bid||1.7900 x 334700|
|Ask||1.7950 x 1317400|
|Day's range||1.7600 - 1.8900|
|52-week range||0.6150 - 2.5200|
|Beta (5Y monthly)||1.32|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||25 Mar 1988|
|1y target est||1.44|
The big shareholder groups in Starpharma Holdings Limited ( ASX:SPL ) have power over the company. Institutions often...
Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that is has signed a Research Agreement with MSD, the tradename of Merck & Co., Inc., Kenilworth NJ USA. Under the agreement, MSD will conduct a preclinical research evaluation of dendrimer based Antibody Drug Conjugates (ADCs) utilising Starpharma's proprietary DEP® technology.
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...